SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001170022-06-000033
Filing Date
2006-06-06
Accepted
2006-06-06 11:20:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13g_belson-elite060506.txt SC 13G 8724
  Complete submission text file 0001170022-06-000033.txt   10535
Mailing Address BELSON ENTERPRISES, INC. 495 BROADWAY NEW YORK NY 10012
Business Address 495 BROADWAY 6TH FLOOR NEW YORK NY 10012 2129419500
BELSON JEROME (Filed by) CIK: 0000900685 (see all company filings)

Type: SC 13G

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Subject) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-59693 | Film No.: 06888290
SIC: 2834 Pharmaceutical Preparations